Need professional-grade analysis? Visit stockanalysis.com
$27.40M
N/A
N/A
N/A
Serina Therapeutics Inc (SER) trades on United States in USD. The company is classified in the Healthcare sector under the Pharmaceutical Preparations industry. The stock currently trades at $1.94, down 0.51% from the previous close.
Over the past year, SER has traded between a low of $1.28 and a high of $6.31. The stock has lost 66.8% over this period. It is currently 69.3% below its 52-week high.
Serina Therapeutics Inc has a market capitalization of $27.40M.
Serina Therapeutics, Inc., a biotechnology company, develops drugs to treat neurological diseases and pain. Its lead product candidate is SER 252 (POZ-apomorphine), a POZ conjugate for the treatment of advanced Parkinson's disease that is in preclinical stage development; and POZ-lipids, a non-immunogenic alternative to the PEG-lipids in the lipid nanoparticles. The company also develops SER 214 a POZ conjugate of rotigotine for the treatment of early Parkinson's and Restless Leg Syndrome, which has completed phase 1a clinical trial. In addition, it develops POZ technology in lipid nanoparticle delivered ribonucleic acid vaccines for infectious diseases. Serina Therapeutics, Inc. was founded in 2006 and is based in Huntsville, Alabama.
Side-by-side comparison against top Healthcare peers.